Adagio Medical Holdings, Inc.ADGMNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +351.22% | -283.33% | -100.00% | -100.00% | -100.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +8.57% | +87.54% | +97.53% | +100.81% | +5.82% |
| Weighted Average Shares Diluted Growth | +8.57% | +87.54% | +97.53% | +100.81% | +5.82% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +28.57% | -50.70% | +0.00% | -100.00% | -100.00% |
| Inventory Growth | +1342.16% | -22.76% | -34.28% | -54.68% | -62.60% |
| Asset Growth | +2273.69% | +609.86% | +343.40% | +344.62% | -70.57% |
| Book Value per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Debt Growth | -53.49% | -57.64% | -61.13% | -65.94% | +57.17% |
| R&D Expense Growth | -44.14% | +92.62% | +5.48% | -31.20% | +12.40% |
| SG&A Expenses Growth | +74.72% | -15.45% | -100.00% | +0.00% | -62.50% |